Drug Type Small molecule drug |
Synonyms APD 405, APD405 |
Mechanism 5-HT receptor antagonists(Serotonin (5-HT) receptor antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H32ClN5O2 |
InChIKeyRICLFGYGYQXUFH-UHFFFAOYSA-N |
CAS Registry33386-08-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nausea | Phase 2 | US | 01 May 2009 | |
Nausea | Phase 2 | FR | 01 May 2009 | |
Nausea | Phase 2 | DE | 01 May 2009 | |
Nausea | Phase 2 | CH | 01 May 2009 | |
Vomiting | Phase 2 | US | 01 May 2009 | |
Vomiting | Phase 2 | FR | 01 May 2009 | |
Vomiting | Phase 2 | DE | 01 May 2009 | |
Vomiting | Phase 2 | CH | 01 May 2009 | |
Postoperative Nausea and Vomiting | Phase 2 | US | 01 May 2009 | |
Postoperative Nausea and Vomiting | Phase 2 | FR | 01 May 2009 |